 |
| Millennium Firm Portfolio - Biotechnology |
|
|
|
 |
|
Dov Pharmaceutical, Inc. (NASDAQ:
DOVP) is a biopharmaceutical company focused on the discovery, in-licensing,
development, and commercialization of novel drug. Millennium invested in Dov
prior to its 2002 IPO and exited in 2004.
|
 |
|
Neurobiological
Technologies, Inc. (NASDAQ: NTII) is a biotechnology company engaged in the
business of acquiring and developing central nervous system (CNS) related drug
candidates. The company is focused on therapies for neurological conditions that
occur in connection with ischemic stroke.
|
|
|
|
|
|
|
|
|
|
|
